ATE140928T1 - Proteine, die die expression von vertebraten-mhc- klasse-ii-genen regulieren, dafür kodierende dna- sequenzen und pharmazeutische zusammensetzungen - Google Patents

Proteine, die die expression von vertebraten-mhc- klasse-ii-genen regulieren, dafür kodierende dna- sequenzen und pharmazeutische zusammensetzungen

Info

Publication number
ATE140928T1
ATE140928T1 AT90906218T AT90906218T ATE140928T1 AT E140928 T1 ATE140928 T1 AT E140928T1 AT 90906218 T AT90906218 T AT 90906218T AT 90906218 T AT90906218 T AT 90906218T AT E140928 T1 ATE140928 T1 AT E140928T1
Authority
AT
Austria
Prior art keywords
genes
mhc class
expression
pharmaceutical compositions
disclosed
Prior art date
Application number
AT90906218T
Other languages
English (en)
Inventor
Bernard Francois Prof Mach
Original Assignee
Mach Bernard Francois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mach Bernard Francois filed Critical Mach Bernard Francois
Application granted granted Critical
Publication of ATE140928T1 publication Critical patent/ATE140928T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT90906218T 1989-04-18 1990-04-18 Proteine, die die expression von vertebraten-mhc- klasse-ii-genen regulieren, dafür kodierende dna- sequenzen und pharmazeutische zusammensetzungen ATE140928T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89106944 1989-04-18
EP89115008 1989-08-14

Publications (1)

Publication Number Publication Date
ATE140928T1 true ATE140928T1 (de) 1996-08-15

Family

ID=26120106

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90906218T ATE140928T1 (de) 1989-04-18 1990-04-18 Proteine, die die expression von vertebraten-mhc- klasse-ii-genen regulieren, dafür kodierende dna- sequenzen und pharmazeutische zusammensetzungen

Country Status (7)

Country Link
EP (1) EP0422175B1 (de)
JP (1) JPH04507400A (de)
AT (1) ATE140928T1 (de)
AU (2) AU5445190A (de)
CA (1) CA2031507A1 (de)
DE (1) DE69027967T2 (de)
WO (1) WO1990012812A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487298A3 (en) * 1990-11-21 1992-12-16 Schering Corporation Human gamma interferon antagonist/agonist screen
WO1994006813A1 (en) * 1992-09-15 1994-03-31 The Rockefeller University Major histocompatibility complex molecules and modifications thereof
AU674891B2 (en) * 1992-10-15 1997-01-16 Toray Industries, Inc. Process for producing major histocompatibility antigen class II protein and material having the same immobilized thereon
CA2168245A1 (en) 1993-07-29 1995-02-09 C. Anthony Hunt Polynucleotide decoys that inhibit mhc-ii expression and uses thereof
US5859226A (en) * 1993-07-29 1999-01-12 Regents Of The University Of California, The Polynucleotide decoys that inhibit MHC-II expression and uses thereof

Also Published As

Publication number Publication date
AU5076393A (en) 1994-02-17
CA2031507A1 (en) 1990-10-19
WO1990012812A1 (en) 1990-11-01
AU5445190A (en) 1990-11-16
JPH04507400A (ja) 1992-12-24
EP0422175A1 (de) 1991-04-17
DE69027967T2 (de) 1997-01-09
DE69027967D1 (de) 1996-09-05
EP0422175B1 (de) 1996-07-31

Similar Documents

Publication Publication Date Title
NO905264D0 (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
ES2091768T3 (es) Factor neurotrofico ciliar purificado.
DK0559884T3 (da) Rekombinante virusvektorer til ekspression i muskelceller
NO882341D0 (no) Ekspresjon av humant proapolipoprotein a-i.
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
EP0232523A3 (en) Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins
ATE307886T1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
DE3856240D1 (de) Herstellung der p1 proteine und impfstoffe gegen gonorrhöe
EP0192175A3 (de) Polypeptide des Rhinovirusstammes HRV2 sowie die hierfür codierenden DNA-Moleküle
ATE140928T1 (de) Proteine, die die expression von vertebraten-mhc- klasse-ii-genen regulieren, dafür kodierende dna- sequenzen und pharmazeutische zusammensetzungen
ES8704184A1 (es) Un metodo para producir un polipeptidos similar a lipocortina humana.
BR9811853A (pt) Processos para aumentar o rendimento em plantas
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
PT883406E (pt) Utilizacao da il-7 no tratamento das doencas auto-imunes em particular a diabetes mellitus insulinodependente
MX9700941A (es) Materiales y metodos para la produccion de icam-4.
ATE278011T1 (de) Human dnase ii
DE3850933D1 (de) Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
AU2002350406A1 (en) Identification of ses-3 (spr-5) in c. elegans and the uses of the same
AU2002314193A1 (en) Identification of ses-1 and the uses of the same
DE69636737D1 (de) Neues immunoregulatorisches protein lst-1
KR880701735A (ko) 골 유도 조성물
MX9804689A (es) Produccion de baculovirus recombinantes.
ATE65543T1 (de) Dna-sequenzen des ebv-genoms, rekombinante dnamolek¨le, verfahren zur herstellung von ebvverwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties